Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-174-2 | CAS number: 79-07-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1982
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to valid testing and GLP guidelines, and was considered relevant, adequate and reliable for classification purpose.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 2-chloroacetamide
- EC Number:
- 201-174-2
- EC Name:
- 2-chloroacetamide
- Cas Number:
- 79-07-2
- Molecular formula:
- C2H4ClNO
- IUPAC Name:
- 2-chloroacetamide
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): Chloracetamide
- Physical state: White crystalline powder
- Analytical purity: Technically pure
- Other: Manufactured by Hoechst AG (Gersthofen) and handed over together with study order dd 1982-03-24; Test solutions were freshly prepared
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: NMRI HOE NMRKf (SPF71)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
-Source: Own breeding (Pharma Forschung Toxikologie, Kastengrund, Hattersheim, Germany)
-Weight : Before first administration males 32-42 g (average 37 g) and females 24-30 g (average 28 g)
-Age: 7-12 weeks
-Housing: Until 5 animals of the same sex per cage with mesh cover (Type 3) on softwood pellets
-Diet: Altromin 1324 (Altromin GmbH, Lage/Lippe (Germany)), ad libitum
-Water: Tap water in plastic drinkers, ad libitum
ENVIRONMENTAL CONDITIONS
-Temperature: 23-26°C
-Humidity: 42-49%
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- desalinated water
- Details on exposure:
- 2x oral dose, 2nd dose given after 24 h
- Duration of treatment / exposure:
- total study period: 30 h
- Frequency of treatment:
- 2 times
- Post exposure period:
- 1st application: 24 h
2nd application: 6 h
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 1, 10, 100 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent no treatment
- Positive control(s):
- 5 males / 5 females, 2x 100 mg Cyclophosphamid / kg bw
same application periods as for the test substance
Examinations
- Tissues and cell types examined:
- Bone marrow: erythrocytes, micronucleus containing cells
- Details of tissue and slide preparation:
- Preparation of the femurs, use gauze to remove muscle tissues from the bone.
Opening of the proximal end, flushing out the bone marrow using 1 mL of fetal calf serum (FCS).
Dilute with FCS and centifuge at 1000/ min, remove supernatant.
Equilibrate sediment & apply 1 drop unto the plate.
Dry 24 h, dye with may-Gruenwalds-solution, wash, dye with Giemsa solution, wash & dry.
Embed in Entellan TM (Merck, Germany) - Evaluation criteria:
- No. of polychromatocytes/Normocytes
Micronucleus containing cells / 2000 polychromatic erythroctes
Micronucleus containing normocytes / 1000 normocytes - Statistics:
- Procedure acc. to Nemenyi; 95 % significance level.The number of micronucleated polychromatic erythrocytes/2000 counted polychromatic erythrocytes and the number of micronucleated normocytes / 1000 counted normocytes was statistically analysed. The binominal distribution was used to examine the increase of micronucleated cells compared to the simultaneous controls.
In addition, the ratio of polychromatic to normochromatic erythrocytes was evaluated statistically. Any differences compared to the simultaneous controls separated by gender were tested by the method of Nemenyi.
Statistacal analysis was perfomed by a computer program, created by the department for practical mathematics of Hoechst AG.
All the statistical results are based on the 95% significance level.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Following all doses of Chloroacetamide, rates of micronucleus-containing polychromatic erythrocytes as well as rates of normocytes were in normally ranges of spontaneous formations and were not significantly different from the values of the control animals.
Ratio of polychromatic erythrocytes vs normocytes were not influenced by chloroacetamide.
Cyclophosphamide induced a markedly increase of micronucleus containing polychromatic erythrocytes.
The increase was statistically significant for both sexes.
Further, the ratio of polychromatic erythrocytes vs normocytes became shifted to the matured cells.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Study results do not indicate chromosome aberrations by chloroacetamide. - Executive summary:
Chloroacetamide was administered to mice by oral gavage twice at an interval of 24 h at doses of 0, 1, 10, 100 mg/kg bw, next to a positive control (Cyclophophamide 100 mg/kg bw).Six hours after the second administration, the animals were sacrificed and the bone marrow obtained from the femurs was processed, smeared on slides and stained. Thereafter, normocytes and polychromatic erythrocytes of each animal were examined for the ratio immature cells / normocytes as well as the number of micronucleated normocytes and polychromatocytes. Chloroacetamide did not result in a significant increase in the number of polychromatic erythrocytes with micronuclei under the conditions of the experiment; the number of micronucleated normocytes also did not show substance related changes. The ratio normocytes/polychromatic erythrocytes in male and female animals in all dose groups was unaffected. The present result do not indicate an induction of chromosomal mutations by Chloroacetamide.
Cyclophosphamide produced a significant increase in the number of micronucleated polychromatic erythrocytes in male and female animals. As an expression of the cytostatic effect of Cyclophosphamide also the ratio normocytes/polychromatic erythrocytes was shifted in favor of the mature cells.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.